Schuh Kai, Quaschning Thomas, Knauer Sebastian, Hu Kai, Kocak Serkan, Roethlein Nicola, Neyses Ludwig
Institute of Clinical Biochemistry and Pathobiochemistry, Versbacher Strasse 5, 97078 Wuerzburg, Germany.
J Biol Chem. 2003 Oct 17;278(42):41246-52. doi: 10.1074/jbc.M307606200. Epub 2003 Aug 4.
The mechanisms governing vascular smooth muscle tone are incompletely understood. In particular, the role of the sarcolemmal calcium pump PMCA (plasma membrane calmodulin-dependent calcium ATPase), which extrudes Ca2+ from the cytosol, and its importance compared with the sodium/calcium exchanger remain speculative. To test whether the PMCA is a regulator of vascular tone, we generated transgenic mice overexpressing the human PMCA4b under control of the arterial smooth muscle-specific SM22alpha promoter. This resulted in an elevated systolic blood pressure compared with littermate controls. In PMCA-overexpressing mice, endothelium-dependent relaxation of norepinephrine-preconstricted aortic rings to acetylcholine did not differ from wild type controls (76 +/- 8% versus 79 +/- 8% of maximum relaxation; n = 12, n.s.). De-endothelialized aortas of transgenic mice exhibited stronger maximum contraction to KCl (100 mmol/liter) compared with controls (86 +/- 6% versus 68 +/- 7% of reference KCl contraction at the beginning of the experiment; p <0.05). Preincubation of de-endothelialized vessels with the nitric oxide synthase (NOS) inhibitor l-NAME (l-N(G)-nitroarginine methyl ester) (10-5 mol/liter) resulted in a stronger contraction to KCl (p <0.05 versus without l-NAME), thus unmasking vasodilatory effects of inherent NO production. Maximum contraction to KCl after preincubation with l-NAME did not differ between PMCA mice and controls. In analogy to the results in PMCA-overexpressing mice, contractions of de-endothelialized aortas of neuronal NOS-deficient mice to KCl were significantly increased compared with controls (151 +/- 5% versus 131 +/- 6% of reference KCl contraction; p <0.05). In conclusion, our data suggest a model in which the sarcolemmal Ca2+ pump down-regulates activity of the vascular smooth muscle Ca2+/calmodulin-dependent neuronal NOS by a functionally relevant interaction. Therefore, the PMCA represents a novel regulator of vascular tone.
目前对调节血管平滑肌张力的机制尚未完全了解。特别是,肌膜钙泵PMCA(质膜钙调蛋白依赖性钙ATP酶)将Ca2+从细胞质中排出的作用,以及与钠/钙交换器相比其重要性仍存在推测。为了测试PMCA是否是血管张力的调节因子,我们构建了在动脉平滑肌特异性SM22α启动子控制下过表达人PMCA4b的转基因小鼠。与同窝对照相比,这导致收缩压升高。在过表达PMCA的小鼠中,去甲肾上腺素预收缩的主动脉环对乙酰胆碱的内皮依赖性舒张与野生型对照无差异(最大舒张的76±8%对79±8%;n = 12,无显著性差异)。转基因小鼠去内皮的主动脉对KCl(100 mmol/L)的最大收缩比对照更强(实验开始时参考KCl收缩的86±6%对68±7%;p<0.05)。用一氧化氮合酶(NOS)抑制剂L-NAME(L-N(G)-硝基精氨酸甲酯)(10-5 mol/L)预孵育去内皮血管会导致对KCl的收缩更强(与未用L-NAME相比,p<0.05),从而揭示了内源性NO产生的血管舒张作用。用L-NAME预孵育后对KCl的最大收缩在PMCA小鼠和对照之间没有差异。与过表达PMCA的小鼠结果类似,神经元NOS缺陷小鼠去内皮的主动脉对KCl的收缩与对照相比显著增加(参考KCl收缩的151±5%对131±6%;p<0.05)。总之,我们的数据表明了一种模型,其中肌膜Ca2+泵通过功能相关的相互作用下调血管平滑肌Ca2+/钙调蛋白依赖性神经元NOS的活性。因此,PMCA代表了一种新型的血管张力调节因子。